United States - English - NLM (National Library of Medicine)

remedyrepack inc. - flumazenil (unii: 40p7xk9392) (flumazenil - unii:40p7xk9392) - flumazenil injection, usp is indicated for the complete or partial reversal of the sedative effects of benzodiazepines in cases where general anesthesia has been induced and/or maintained with benzodiazepines, where sedation has been produced with benzodiazepines for diagnostic and therapeutic procedures, and for the management of benzodiazepine overdose. flumazenil injection, usp is indicated for the reversal of conscious sedation induced with benzodiazepines (see precautions , pediatric use ). flumazenil injection, usp is contraindicated: • in patients with a known hypersensitivity to flumazenil or benzodiazepines. • in patients who have been given a benzodiazepine for control of a potentially life-threatening condition (e.g., control of intracranial pressure or status epilepticus). • in patients who are showing signs of serious cyclic antidepressant overdose (see warnings ). flumazenil acts as a benzodiazepine antagonist, blocks the effects of benzodiazepines in animals and man, antagonizes benzodiazepine reinforcement in animal models, produces dysphoria in normal subjects, and has had no reported abuse in foreign marketing. although flumazenil has a benzodiazepine-like structure it does not act as a benzodiazepine agonist in man and is not a controlled substance.

Israel - English - Ministry of Health

genmedix , israel - flumazenil - solution for injection - flumazenil 0.1 mg/ml - flumazenil - flumazenil - benzodiazepine antagonist for reversal of benzodiazepine anesthesia, as well as for patients with benzodiazepine intoxication.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - flumazenil, quantity: 0.1 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; glacial acetic acid; sodium chloride; disodium edetate; water for injections - flumazenil is indicated for use in hospitalised patients for the reversal of acute benzodiazepine effects (overdose or therapeutic). hospitalised patients are patients admitted to hospital, inpatient care and under continued professional observation while under the influence of flumazenil. not to be used in outpatients or short stay patients. not to be used as a diagnostic.

United States - English - NLM (National Library of Medicine)

henry schein, inc - flumazenil (unii: 40p7xk9392) (flumazenil - unii:40p7xk9392) - adult patients: flumazenil injection is indicated for the complete or partial reversal of the sedative effects of benzodiazepines in cases where general anesthesia has been induced and/or maintained with benzodiazepines, where sedation has been produced with benzodiazepines for diagnostic and therapeutic procedures, and for the management of benzodiazepine overdose. pediatric patients (aged 1 to 17): flumazenil injection is indicated for the reversal of conscious sedation induced with benzodiazepines (see precautions: pediatric use). flumazenil injection is contraindicated: •in patients with a known hypersensitivity to flumazenil or benzodiazepines. •in patients who have been given a benzodiazepine for control of a potentially life-threatening condition (e.g., control of intracranial pressure or status epilepticus). •in patients who are showing signs of serious cyclic antidepressant overdose (see warnings). flumazenil acts as a benzodiazepine antagonist, blocks the effects of benzodiazepines in animals and

United States - English - NLM (National Library of Medicine)

henry schein, inc - flumazenil (unii: 40p7xk9392) (flumazenil - unii:40p7xk9392) - adult patients: flumazenil injection is indicated for the complete or partial reversal of the sedative effects of benzodiazepines in cases where general anesthesia has been induced and/or maintained with benzodiazepines, where sedation has been produced with benzodiazepines for diagnostic and therapeutic procedures, and for the management of benzodiazepine overdose. pediatric patients (aged 1 to 17): flumazenil injection is indicated for the reversal of conscious sedation induced with benzodiazepines (see precautions: pediatric use). close contraindications flumazenil injection is contraindicated: •in patients with a known hypersensitivity to flumazenil or benzodiazepines. •in patients who have been given a benzodiazepine for control of a potentially life-threatening condition (e.g., control of intracranial pressure or status epilepticus). •in patients who are showing signs of serious cyclic antidepressant overdose (see warnings). flumazenil injection is contraindicated: •in patients with a known hypersen

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - flumazenil, quantity: 1 mg - injection, solution - excipient ingredients: water for injections; sodium chloride; disodium edetate; acetic acid; sodium hydroxide - flumazenil is indicated for use in hospitalised patients for the reversal of acute benzodiazepine effects (overdose or therapeutic). hospitalised patients are patients admitted to hospital, inpatient care and under continued professional observation while under the influence of flumazenil. not to be used in outpatients or short stay patients. not to be used as a diagnostic.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - flumazenil, quantity: 0.5 mg - injection, solution - excipient ingredients: sodium hydroxide; sodium chloride; disodium edetate; acetic acid; water for injections - flumazenil is indicated for use in hospitalised patients for the reversal of acute benzodiazepine effects (overdose or therapeutic). hospitalised patients are patients admitted to hospital, inpatient care and under continued professional observation while under the influence of flumazenil. not to be used in outpatients or short stay patients. not to be used as a diagnostic.

United States - English - NLM (National Library of Medicine)

hf acquisition co. llc, dba healthfirst - flumazenil (unii: 40p7xk9392) (flumazenil - unii:40p7xk9392) - flumazenil is contraindicated: in patients with a known hypersensitivity to flumazenil or benzodiazepines. in patients who have been given a benzodiazepine for control of a potentially life-threatening condition (e.g., control of intracranial pressure or status epilepticus). in patients who are showing signs of serious cyclic antidepressant overdose (see warnings). flumazenil acts as a benzodiazepine antagonist, blocks the effect of benzodiazepines in animals and man, antagonizes benzodiazepine reinforcement in animal models, produces dysphoria in normal subjects, and has had no reported abuse in foreign marketing. although flumazenil has a benzodiazepine-like structure it does not act as a benzodiazepine agonist in man and is not a controlled substance.

United States - English - NLM (National Library of Medicine)

medical purchasing solutions, llc - flumazenil (unii: 40p7xk9392) (flumazenil - unii:40p7xk9392) - flumazenil injection is indicated for the complete or partial reversal of the sedative effects of benzodiazepines in cases where general anesthesia has been induced and/or maintained with benzodiazepines, where sedation has been produced with benzodiazepines for diagnostic and therapeutic procedures, and for the management of benzodiazepine overdose. flumazenil injection is indicated for the reversal of conscious sedation induced with benzodiazepines (see precautions: pediatric use ). flumazenil injection is contraindicated: - in patients with a known hypersensitivity to flumazenil or benzodiazepines. - in patients who have been given a benzodiazepine for control of a potentially life-threatening condition (e.g., control of intracranial pressure or status epilepticus). - in patients who are showing signs of serious cyclic antidepressant overdose (see warnings ). flumazenil acts as a benzodiazepine antagonist, blocks the effects of benzodiazepines in animals and man, antagonizes

United States - English - NLM (National Library of Medicine)

west-ward pharmaceutical corp. - flumazenil (unii: 40p7xk9392) (flumazenil - unii:40p7xk9392) - flumazenil injection is indicated for the complete or partial reversal of the sedative effects of benzodiazepines in cases where general anesthesia has been induced and/or maintained with benzodiazepines, where sedation has been produced with benzodiazepines for diagnostic and therapeutic procedures, and for the management of benzodiazepine overdose. flumazenil injection is indicated for the reversal of conscious sedation induced with benzodiazepines (see precautions: pediatric use ). flumazenil injection is contraindicated: - in patients with a known hypersensitivity to flumazenil or benzodiazepines. - in patients who have been given a benzodiazepine for control of a potentially life-threatening condition (e.g., control of intracranial pressure or status epilepticus). - in patients who are showing signs of serious cyclic antidepressant overdose (see warnings ). flumazenil injection acts as a benzodiazepine antagonist, blocks the effects of benzodiazepines in animals and man, antagonizes benzodiazepine reinfo